Generated by DeepSeek V3.2| Michael Berridge | |
|---|---|
| Name | Michael Berridge |
| Birth date | 22 October 1938 |
| Birth place | Mount Darwin, Southern Rhodesia |
| Death date | 13 February 2020 |
| Death place | Cambridge, England |
| Nationality | British |
| Fields | Cell biology, Biochemistry |
| Workplaces | University of Cambridge, Babraham Institute |
| Alma mater | University of Rhodesia and Nyasaland, University of Cambridge |
| Known for | Discovery of inositol trisphosphate as a second messenger |
| Awards | Royal Medal (1991), Wolf Prize in Medicine (1994/95), Albert Lasker Award for Basic Medical Research (1989), Louis-Jeantet Prize for Medicine (1986), Fellow of the Royal Society (1984) |
Michael Berridge was a pioneering British biochemist and cell biologist renowned for his fundamental discovery of inositol trisphosphate (IP3) as a crucial second messenger in cellular signal transduction. His work, conducted primarily at the Babraham Institute in Cambridge, revolutionized the understanding of how hormones and neurotransmitters regulate processes within cells, influencing fields from physiology to pharmacology. For this seminal contribution, he received numerous prestigious awards including the Royal Medal, the Wolf Prize in Medicine, and the Albert Lasker Award for Basic Medical Research.
Born in Mount Darwin, Southern Rhodesia (now Zimbabwe), Berridge pursued his initial higher education at the University of Rhodesia and Nyasaland, earning a Bachelor of Science degree. He then moved to England for doctoral studies at the University of Cambridge, where he completed his PhD in entomology under the supervision of Sir Vincent Wigglesworth, a leading figure in insect physiology. His early research focused on the salivary gland of the blowfly, work that would later provide the critical experimental system for his groundbreaking discoveries in cell signaling.
Following his PhD, Berridge undertook postdoctoral research at the University of Virginia before returning to the United Kingdom to join the Agricultural Research Council's Unit of Invertebrate Chemistry and Physiology at the University of Cambridge. In 1975, he moved his laboratory to the Babraham Institute, where he spent the majority of his career. His research program was dedicated to unraveling the mechanisms of calcium signaling, investigating how external stimuli like acetylcholine and serotonin trigger the release of calcium ions from intracellular stores within endoplasmic reticulum. This work positioned him at the forefront of molecular biology and cell physiology.
Berridge's most celebrated achievement was the identification of inositol trisphosphate (IP3) as a second messenger. In a seminal series of experiments in the early 1980s, using the blowfly salivary gland as a model, he and his colleagues demonstrated that the binding of a hormone to a cell surface receptor activates phospholipase C. This enzyme cleaves the membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2) to generate IP3, which then diffuses into the cytoplasm and binds to specific receptors on the endoplasmic reticulum, triggering the release of stored calcium ions. This IP<sub>3</sub> receptor-mediated pathway, often called the phosphoinositide pathway, was found to be a universal signaling mechanism in eukaryotes, influencing everything from muscle contraction and neurotransmitter release to gene expression and cell proliferation.
Berridge's contributions were recognized with a cascade of major international awards. He was elected a Fellow of the Royal Society in 1984. His honors include the Louis-Jeantet Prize for Medicine (1986), the Gairdner Foundation International Award (1988), the Albert Lasker Award for Basic Medical Research (1989, shared with Alfred G. Gilman and Edwin G. Krebs), the Royal Medal of the Royal Society (1991), and the Wolf Prize in Medicine (1994/95, shared with Yoshio Masui and James D. Watson). He also received the Sir Hans Krebs Medal from the Federation of European Biochemical Societies.
Berridge was known as a modest and dedicated scientist who preferred the laboratory to the limelight. He was married and had two children. His legacy is profound, having established one of the central paradigms of modern cell biology. The IP<sub>3</sub> signaling pathway he elucidated is a fundamental target for drug development in areas such as cardiology, neurology, and oncology. His work continues to inspire research in signal transduction across the globe, cementing his status as one of the most influential biochemists of the late 20th century.
Category:1938 births Category:2020 deaths Category:British biochemists Category:British cell biologists Category:Fellows of the Royal Society Category:Wolf Prize in Medicine laureates Category:Albert Lasker Award for Basic Medical Research recipients Category:University of Cambridge alumni Category:People from Mount Darwin, Zimbabwe